Loading data
SANANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 131.98 m USD | 215.67 m USD | 261.81 m USD | 285.89 m USD | 248.63 m USD |
| Operating profit | -250.32 m USD | -272.72 m USD | -293.14 m USD | -272.56 m USD | -356.91 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -244.17 m USD | -266.76 m USD | -283.26 m USD | -269.48 m USD | -355.93 m USD |
| Basic earnings per share | -0.96 USD/share | -1.16 USD/share | -1.46 USD/share | -1.43 USD/share | -2.14 USD/share |
| Diluted earnings per share | -0.96 USD/share | -1.16 USD/share | -1.46 USD/share | -1.43 USD/share | -2.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.